- Fecal Incontinence
|Health Care Resource Use and Costs Pre- and Post-Treatment Initiation With Linaclotide: Retrospective Analyses of a U.S. Insured Population
Taylor DC1, Abel JL2, Bancroft T3, Buzinec P3, Goolsby Hunter A3, Carson RT2, Martin C3. Manag Care. 2018 Feb;27(2):33-40.
1 Ironwood Pharmaceuticals Inc., Cambridge, Mass.
2 Allergan plc, Jersey City, N.J.
3 Optum, Eden Prairie, Minn.
As expected, pharmacy costs increased with the introduction of this new treatment in a market dominated by over-the-counter and generic treatments. On the other hand, outpatient GI-related and irritable bowel diseasehealth care resource use and costs substantially decreased among commercial and Medicare patients following linaclotide treatment initiation.